The potent inhibitory activity of AChE and BChE indicates the potential use of these derivatives in the treatment of neurodegenerative diseases, while the ability to inhibit α-glucosidase suggests potential use in the treatment of type 2 diabetes by reducing carbohydrate absorption [37]. The gene discussed is BCHE; the disease is neurodegenerative disease.